Literature DB >> 34205965

Downregulation of CD73/A2AR-Mediated Adenosine Signaling as a Potential Mechanism of Neuroprotective Effects of Theta-Burst Transcranial Magnetic Stimulation in Acute Experimental Autoimmune Encephalomyelitis.

Milorad Dragić1, Milica Zeljković1, Ivana Stevanović2,3, Marija Adžić1, Andjela Stekić1, Katarina Mihajlović1, Ivana Grković4, Nela Ilić5,6, Tihomir V Ilić3, Nadežda Nedeljković1, Milica Ninković2,3.   

Abstract

Multiple sclerosis (MS) is a chronic neurodegenerative disease caused by autoimmune-mediated inflammation in the central nervous system. Purinergic signaling is critically involved in MS-associated neuroinflammation and its most widely applied animal model-experimental autoimmune encephalomyelitis (EAE). A promising but poorly understood approach in the treatment of MS is repetitive transcranial magnetic stimulation. In the present study, we aimed to investigate the effect of continuous theta-burst stimulation (CTBS), applied over frontal cranial bone, on the adenosine-mediated signaling system in EAE, particularly on CD73/A2AR/A1R in the context of neuroinflammatory activation of glial cells. EAE was induced in two-month-old female DA rats and in the disease peak treated with CTBS protocol for ten consecutive days. Lumbosacral spinal cord was analyzed immunohistochemically for adenosine-mediated signaling components and pro- and anti-inflammatory factors. We found downregulated IL-1β and NF- κB-ir and upregulated IL-10 pointing towards a reduction in the neuroinflammatory process in EAE animals after CTBS treatment. Furthermore, CTBS attenuated EAE-induced glial eN/CD73 expression and activity, while inducing a shift in A2AR expression from glia to neurons, contrary to EAE, where tight coupling of eN/CD73 and A2AR on glial cells is observed. Finally, increased glial A1R expression following CTBS supports anti-inflammatory adenosine actions and potentially contributes to the overall neuroprotective effect observed in EAE animals after CTBS treatment.

Entities:  

Keywords:  A1R; A2AR; CD73; adenosine; neuroinflammation; purinergic signaling; rTMS; theta-burst stimulation

Year:  2021        PMID: 34205965     DOI: 10.3390/brainsci11060736

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  4 in total

1.  Intermittent Theta Burst Stimulation Ameliorates Cognitive Deficit and Attenuates Neuroinflammation via PI3K/Akt/mTOR Signaling Pathway in Alzheimer's-Like Disease Model.

Authors:  Andjela Stekic; Milica Zeljkovic; Marina Zaric Kontic; Katarina Mihajlovic; Marija Adzic; Ivana Stevanovic; Milica Ninkovic; Ivana Grkovic; Tihomir V Ilic; Nadezda Nedeljkovic; Milorad Dragic
Journal:  Front Aging Neurosci       Date:  2022-05-17       Impact factor: 5.702

2.  Modern Developments in Transcranial Magnetic Stimulation: The Editorial.

Authors:  Nico Sollmann; Petro Julkunen
Journal:  Brain Sci       Date:  2022-05-11

Review 3.  Clinical application of transcranial magnetic stimulation in multiple sclerosis.

Authors:  Xiaoliang Zhou; Kailin Li; Si Chen; Wenbin Zhou; Jing Li; Qing Huang; Tingting Xu; Zhiyuan Gao; Dongyu Wang; Shuo Zhao; Hao Dong
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

4.  Adenosine A2A Receptor Antagonist Improves Cognitive Impairment by Inhibiting Neuroinflammation and Excitatory Neurotoxicity in Chronic Periodontitis Mice.

Authors:  Wendan He; Xianlong Xie; Chenxi Li; Huang Ding; Jishi Ye
Journal:  Molecules       Date:  2022-09-23       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.